HGH Fragment 176-191
A stabilized analogue of the C-terminal region (residues 176-191) of human growth hormone. Research indicates this fragment retains the lipolytic activity of full-length HGH without binding to GH receptors or influencing IGF-1 levels — making it an ideal isolated research model.
Research Use Only. HGH Fragment 176-191 is sold exclusively for in vitro research and laboratory use by qualified scientists. Not for human consumption, veterinary use, or clinical administration.
Research Literature
Published Research
HGH Fragment 176-191 retains the lipolytic activity of full-length HGH without receptor binding or IGF-1 effects.
AOD9604 and HGH fragment metabolism studies
Key finding: C-terminal HGH fragment demonstrates selective lipolysis without growth-promoting or diabetogenic effects.
PubMed 10417774 ↗HGH 176-191 lipolytic activity in adipose tissue
Key finding: Fragment activates beta-adrenergic receptors in fat tissue independently of full-length GH receptor.
PubMed 12126431 ↗GH fragment safety and metabolic effects
Key finding: No IGF-1 elevation or glucose impairment observed at lipolytically active doses.
PubMed 15272051 ↗Same Category